Avingtrans PLC

Director Shareholdings, Exercise of Options & TVR

RNS Number : 2153U
Avingtrans PLC
01 April 2021
 

1 April 2021 

 

Avingtrans Plc

("Avingtrans" or the "Company" or the "Group")

 

Director Shareholdings, Exercise of EBT Options and Total Voting Rights

 

Avingtrans plc, which designs, manufactures and supplies critical components, modules and associated services to the energy and medical sectors, announces certain dealings in its shares.

Shares Awarded Under Joint Ownership EBT

107,906 ordinary shares are to be awarded to certain PDMRs of the Company out of the Company's Employee Benefit Trust (the "EBT Shares"). The details of these awards, together with the resultant shareholdings, are set out below.

Name

Role

Current shareholding

Number of shares awarded

Resultant shareholding

Resultant percentage holding

Steve McQuillan

Chief Executive Officer

311,492

40,109

351,601(1)

1.10%

Stephen King

Chief Financial Officer

274,788

35,465

310,253(2)

0.97%

Austen Adams

MD, Process Solutions & Rotating Equipment

5,000

32,332

37,332

0.12%

(1)  This figure includes 295,473 held by Sheena McQuillan

(2)  This figure includes 274,788 held by Helen King

Total Voting Rights

There's is no change due to the above, the Company will have a total of 31,938,307 ordinary shares in issue. The Company does not hold any shares in Treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

 

Avingtrans plc

01354692391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer Stephen King,ChiefFinancialOfficer

N+1 Singer(NominatedAdviser)

02074963000

Shaun Dobson/Alex Bond(CorporateFinance)RachelHayes(CorporateBroking)

SEC Newgate (Financial PR)

02076539850

Adam Lloyd/ Tom Carnegie

 

About Avingtrans plc:

Avingtrans  designs,  manufactures  and  supplies  original  equipment,  systems  and  associated aftermarket services to the energy, medical and industrial markets worldwide.

 

Business units

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

 

Energy Steel, Inc - Lapeer, Michigan, USA

Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support.

 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub- assemblies and systems.

 

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast

&explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

 

Ormandy Group, Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

 

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

 

Tecmag Inc, Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has remained at the forefront of MRI systems technology, successfully designing and commercialising a 1.5 Tesla extremity MRI superconducting magnet that is now the heart of over two hundred MRI systems world-wide. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Steve McQuillan

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each



Identification code

ISIN: GB0009188797

 



b)

 

Nature of the transaction

 

 

Award of Shares

 

c)

 

Price(s) and volume(s)







Exercise Price(s)

Volume(s)

Nil

40,109



d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

31 March 2021

f)

 

Place of the transaction

 

 

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stephen King

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each



Identification code

ISIN: GB0009188797

 



b)

 

Nature of the transaction

 

 

Award of Shares

 

c)

 

Price(s) and volume(s)







Exercise Price(s)

Volume(s)

Nil

35,465



d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

31 March 2021

f)

 

Place of the transaction

 

 

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Austen Adams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each



Identification code

ISIN: GB0009188797

 



b)

 

Nature of the transaction

 

 

Award of Shares

 

c)

 

Price(s) and volume(s)







Exercise Price(s)

Volume(s)

Nil

32,332



d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

31 March 2021

f)

 

Place of the transaction

 

 

Off market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSDAFUFEFSESD